ArticleHaematologica2022

High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL.

Aurelie Cabannes-Hamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.